查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1572314

胆红素血液检测市场：按测试类型、最终用户、应用、产品 - 2025-2030 年全球预测

Bilirubin Blood Test Market by Test Type (Delta Bilirubin Test, Direct Bilirubin Test, Indirect Bilirubin Test), End User (Ambulatory Surgical Centers, Diagnostic Laboratories, Home Care Settings), Application, Product - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年胆红素血液检测市值为10.9亿美元，预计到2024年将达到12亿美元，复合年增长率为10.73%，预计到2030年将达到22.3亿美元。

胆红素血液检测市场包括测量血液中胆红素浓度的诊断程序，这对于肝病、溶血性贫血和新生儿黄疸的诊断和监测至关重要。生活方式改变、饮酒和肝炎等病毒感染引起的肝损伤日益普遍，强调了对这些检查的必要性。最终用途主要包括医院、诊断实验室和门诊护理中心，每个地方都需要准确、及时的诊断服务来帮助病患管理。市场成长受到对先进诊断技术的需求不断增长、人们对肝臟健康的认识不断提高以及更容易患肝病的老年人口不断增加的影响。此外，就地检验和非侵入性诊断工具的开发等技术创新提供了巨大的成长机会。投资研发更准确、更方便的测试的公司将充分利用快速成长的需求。然而，市场面临严格的监管要求和与先进测试技术相关的高成本等挑战，这可能会限制小规模的测试设施和新兴国家。在创新方面，探索人工智慧主导的诊断工具以提高测试准确性和患者治疗结果具有广阔的前景。此外，对家庭环境中胆红素测试更加无缝整合的研究可能会开拓新的细分市场。儘管有这些机会，但市场在一定程度上受到新兴市场意识低落和医疗基础设施不足的限制，凸显了教育宣传活动和基础设施投资的必要性。总体而言，透过技术进步和策略联盟来提高测试的可及性、准确性和可负担性对于市场参与者在克服现有限制的同时开拓这一利基市场至关重要。随着市场的发展，它将为创新提供肥沃的土壤，特别是在个人化医疗和行动医疗技术方面。

主要市场统计
基准年[2023] 10.9亿美元
预测年份 [2024] 12亿美元
预测年份 [2030] 22.3亿美元
复合年增长率（%） 10.73%

市场动态：快速发展的胆红素血液检测市场的关键市场洞察

供需的动态交互作用正在改变胆红素血液检测市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 由于新生儿保健服务的扩大，对新生儿胆红素检测的需求增加
    • 就地检验的普及有助于方便、快速地获得胆红素结果
    • 需要频繁监测胆红素的溶血性疾病发生率不断增加，有助于市场成长
    • 政府卫生政策和资金推动胆红素检测的进步和可及性
  • 市场限制因素
    • 缺乏接受过胆红素检测技术培训的熟练医疗保健专业人员，特别是在农村地区
    • 新胆红素检测方法和技术的监管核准过程漫长；
  • 市场机会
    • 支持在农村推广胆红素血液检测的医疗保健政策
    • 由于对新生儿黄疸的认识不断提高，对胆红素检测的需求增加
    • 医院与研究机构伙伴关係开发创新胆红素检测解决方案
  • 市场挑战
    • 供应链中断影响胆红素血液检测套组的及时且经济高效的分发
    • 核准过程中的监管挑战导致创新胆红素检测技术的引入延迟

波特的五力：驾驭胆红素血液检测市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解胆红素血液检测市场的外部影响

外部宏观环境因素在塑造胆红素血液检测市场的表现动态中起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解胆红素血液检测市场的竞争格局

对胆红素血液检测市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵胆红素血液检测市场供应商的绩效评估

FPNV定位矩阵是评估胆红素血液检测市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划胆红素血液检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，胆红素血液检测市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 新生儿保健服务的扩展增加了新生儿胆红素检测的需求
      • 随着医疗环境检测的迅速增加，现在可以方便快速地获得胆红素水平的检测结果。
      • 需要频繁监测胆红素的溶血性疾病发生率上升有助于市场成长
      • 促进胆红素检测的进步和可近性的政府卫生政策和资金
    • 抑制因素
      • 缺乏接受过胆红素检测技术训练的熟练医护人员，特别是在农村地区。
      • 新胆红素检测方法和技术的监管核准流程较长
    • 机会
      • 支持在农村地区广泛使用胆红素血液检测的医疗保健政策
      • 对新生儿黄疸的认识提高增加了对胆红素检测的需求
      • 医院与研究机构合作开发创新胆红素检测解决方案
    • 任务
      • 供应链中断导致胆红素血液检测套组无法及时且经济有效地分发
      • 核准过程中的监管挑战延迟了创新胆红素测试技术的引入
  • 市场区隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章胆红素血液检测市场：依测试类型

  • Delta胆红素测试
  • 直接胆红素（DBIL）测试
  • 间接胆红素（IBIL）测试
  • 血清总胆红素（TSB）测试
    • 直接（结合）胆红素测试
    • 间接（非结合）胆红素测试

第七章胆红素血液检测市场：依最终用户分类

  • 日间手术中心 (ASC)
  • 诊断实验室
  • 家庭护理设置
  • 医院
  • 研究所

第八章胆红素血液检测市场：依应用分类

  • 胆管阻塞
  • 药物相关毒性
  • 溶血性贫血
  • 肝臟疾病
  • 新生儿黄疸

第九章胆红素血液检测市场：副产品

  • 装置
  • 试剂和套件

第十章美洲胆红素血液检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太胆红素血液检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲胆红素血液检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C0149

The Bilirubin Blood Test Market was valued at USD 1.09 billion in 2023, expected to reach USD 1.20 billion in 2024, and is projected to grow at a CAGR of 10.73%, to USD 2.23 billion by 2030.

The bilirubin blood test market, encompassing diagnostic procedures to measure bilirubin levels in the blood, is pivotal in diagnosing and monitoring liver diseases, hemolytic anemia, and neonatal jaundice. The necessity of these tests is underscored by the increasing prevalence of liver disorders, driven by lifestyle changes, alcohol consumption, and viral infections like hepatitis. End-use applications predominantly include hospitals, diagnostic laboratories, and outpatient care centers, each requiring precise and timely diagnostic services to aid in patient management. Market growth is influenced by the rising demand for advanced diagnostic techniques, heightened awareness about liver health, and the increasing geriatric population, prone to liver diseases. Additionally, technological innovations such as point-of-care testing and the development of non-invasive diagnostic tools present substantial growth opportunities. Companies investing in R&D for more accurate and accessible testing methods stand to capitalize on the burgeoning demand. However, the market faces challenges like stringent regulatory requirements and the high costs associated with advanced testing technologies, which may constrain smaller laboratories and emerging economies. In terms of innovation, there is promising potential in exploring artificial intelligence-driven diagnostic tools to enhance test accuracy and patient outcomes. Additionally, research into more seamless integration of bilirubin testing in home-based settings could open new market segments. Despite these opportunities, the market is somewhat constrained by the lack of awareness and inadequate healthcare infrastructure in developing regions, highlighting a need for educational campaigns and infrastructure investments. Overall, focusing on enhancing test accessibility, accuracy, and affordability through technological advancements and strategic partnerships would be pivotal for market players to exploit this niche while overcoming existing limitations. As the market evolves, it presents a fertile ground for innovation, particularly in personalized medicine and mobile health technologies.

KEY MARKET STATISTICS
Base Year [2023] USD 1.09 billion
Estimated Year [2024] USD 1.20 billion
Forecast Year [2030] USD 2.23 billion
CAGR (%) 10.73%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bilirubin Blood Test Market

The Bilirubin Blood Test Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expansion of neonatal healthcare services increasing demand for bilirubin testing in newborns
    • Surge in point-of-care testing driving convenience and faster results for bilirubin levels
    • Higher incidence of hemolytic diseases requiring frequent bilirubin monitoring contributing to market growth
    • Government health policies and funding favoring advancements and accessibility of bilirubin testing
  • Market Restraints
    • Shortage of skilled healthcare professionals trained in bilirubin testing techniques, especially in rural areas
    • Long approval process for new bilirubin test methods and technologies by regulatory bodies
  • Market Opportunities
    • Healthcare policies supporting widespread adoption of bilirubin blood tests in rural areas
    • Rising awareness about neonatal jaundice leading to increased bilirubin testing demand
    • Partnerships between hospitals and research institutions for innovative bilirubin test solutions
  • Market Challenges
    • Supply chain disruptions affecting timely and cost-efficient distribution of bilirubin blood test kits
    • Regulatory challenges in approval processes leading to delayed introduction of innovative bilirubin testing technologies

Porter's Five Forces: A Strategic Tool for Navigating the Bilirubin Blood Test Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bilirubin Blood Test Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bilirubin Blood Test Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bilirubin Blood Test Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bilirubin Blood Test Market

A detailed market share analysis in the Bilirubin Blood Test Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bilirubin Blood Test Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bilirubin Blood Test Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bilirubin Blood Test Market

A strategic analysis of the Bilirubin Blood Test Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bilirubin Blood Test Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Beckman Coulter, Bio-Rad Laboratories, DiaSorin, Fujifilm Holdings Corporation, GE Healthcare, Horiba Medical, Mindray, PerkinElmer, Philips Healthcare, Quidel Corporation, Randox Laboratories, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, Tosoh Bioscience, and Trinity Biotech.

Market Segmentation & Coverage

This research report categorizes the Bilirubin Blood Test Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Test Type, market is studied across Delta Bilirubin Test, Direct Bilirubin (DBIL) Test, Indirect Bilirubin (IBIL) Test, and Total Serum Bilirubin (TSB) Test. The Total Serum Bilirubin (TSB) Test is further studied across Direct (Conjugated) Bilirubin Test and Indirect (Unconjugated) Bilirubin Test.
  • Based on End User, market is studied across Ambulatory Surgical Centers (ASCs), Diagnostic Laboratories, Home Care Settings, Hospitals, and Research Institutes.
  • Based on Application, market is studied across Bile Duct Obstruction, Drug-Related Toxicity, Hemolytic Anemia, Liver Diseases, and Newborn Jaundice.
  • Based on Product, market is studied across Instruments and Reagents & Kits.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expansion of neonatal healthcare services increasing demand for bilirubin testing in newborns
      • 5.1.1.2. Surge in point-of-care testing driving convenience and faster results for bilirubin levels
      • 5.1.1.3. Higher incidence of hemolytic diseases requiring frequent bilirubin monitoring contributing to market growth
      • 5.1.1.4. Government health policies and funding favoring advancements and accessibility of bilirubin testing
    • 5.1.2. Restraints
      • 5.1.2.1. Shortage of skilled healthcare professionals trained in bilirubin testing techniques, especially in rural areas
      • 5.1.2.2. Long approval process for new bilirubin test methods and technologies by regulatory bodies
    • 5.1.3. Opportunities
      • 5.1.3.1. Healthcare policies supporting widespread adoption of bilirubin blood tests in rural areas
      • 5.1.3.2. Rising awareness about neonatal jaundice leading to increased bilirubin testing demand
      • 5.1.3.3. Partnerships between hospitals and research institutions for innovative bilirubin test solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Supply chain disruptions affecting timely and cost-efficient distribution of bilirubin blood test kits
      • 5.1.4.2. Regulatory challenges in approval processes leading to delayed introduction of innovative bilirubin testing technologies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bilirubin Blood Test Market, by Test Type

  • 6.1. Introduction
  • 6.2. Delta Bilirubin Test
  • 6.3. Direct Bilirubin (DBIL) Test
  • 6.4. Indirect Bilirubin (IBIL) Test
  • 6.5. Total Serum Bilirubin (TSB) Test
    • 6.5.1. Direct (Conjugated) Bilirubin Test
    • 6.5.2. Indirect (Unconjugated) Bilirubin Test

7. Bilirubin Blood Test Market, by End User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers (ASCs)
  • 7.3. Diagnostic Laboratories
  • 7.4. Home Care Settings
  • 7.5. Hospitals
  • 7.6. Research Institutes

8. Bilirubin Blood Test Market, by Application

  • 8.1. Introduction
  • 8.2. Bile Duct Obstruction
  • 8.3. Drug-Related Toxicity
  • 8.4. Hemolytic Anemia
  • 8.5. Liver Diseases
  • 8.6. Newborn Jaundice

9. Bilirubin Blood Test Market, by Product

  • 9.1. Introduction
  • 9.2. Instruments
  • 9.3. Reagents & Kits

10. Americas Bilirubin Blood Test Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Bilirubin Blood Test Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Bilirubin Blood Test Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies
  • 3. Beckman Coulter
  • 4. Bio-Rad Laboratories
  • 5. DiaSorin
  • 6. Fujifilm Holdings Corporation
  • 7. GE Healthcare
  • 8. Horiba Medical
  • 9. Mindray
  • 10. PerkinElmer
  • 11. Philips Healthcare
  • 12. Quidel Corporation
  • 13. Randox Laboratories
  • 14. Roche Diagnostics
  • 15. Siemens Healthineers
  • 16. Sysmex Corporation
  • 17. Thermo Fisher Scientific
  • 18. Tosoh Bioscience
  • 19. Trinity Biotech

LIST OF FIGURES

  • FIGURE 1. BILIRUBIN BLOOD TEST MARKET RESEARCH PROCESS
  • FIGURE 2. BILIRUBIN BLOOD TEST MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BILIRUBIN BLOOD TEST MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BILIRUBIN BLOOD TEST MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BILIRUBIN BLOOD TEST MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BILIRUBIN BLOOD TEST MARKET DYNAMICS
  • TABLE 7. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DELTA BILIRUBIN TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DIRECT BILIRUBIN (DBIL) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY INDIRECT BILIRUBIN (IBIL) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DIRECT (CONJUGATED) BILIRUBIN TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY INDIRECT (UNCONJUGATED) BILIRUBIN TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY BILE DUCT OBSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DRUG-RELATED TOXICITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY HEMOLYTIC ANEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY LIVER DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY NEWBORN JAUNDICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 239. BILIRUBIN BLOOD TEST MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 240. BILIRUBIN BLOOD TEST MARKET, FPNV POSITIONING MATRIX, 2023